CN102935163B - The Chinese medicine preparation for the treatment of hyperosteogeny - Google Patents
The Chinese medicine preparation for the treatment of hyperosteogeny Download PDFInfo
- Publication number
- CN102935163B CN102935163B CN201210488206.4A CN201210488206A CN102935163B CN 102935163 B CN102935163 B CN 102935163B CN 201210488206 A CN201210488206 A CN 201210488206A CN 102935163 B CN102935163 B CN 102935163B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- fructus
- hyperosteogeny
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 241000628997 Flos Species 0.000 claims abstract description 11
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 210000004185 liver Anatomy 0.000 abstract description 21
- 210000003734 kidney Anatomy 0.000 abstract description 20
- 230000001737 promoting effect Effects 0.000 abstract description 15
- 239000008280 blood Substances 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 10
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 abstract description 10
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 230000017423 tissue regeneration Effects 0.000 abstract description 5
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 210000000952 spleen Anatomy 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 11
- 210000000988 bone and bone Anatomy 0.000 description 9
- 208000006820 Arthralgia Diseases 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 201000008482 osteoarthritis Diseases 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 230000003014 reinforcing effect Effects 0.000 description 5
- 230000007850 degeneration Effects 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 238000000554 physical therapy Methods 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000003119 painkilling effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010050256 Dysstasia Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 201000010934 exostosis Diseases 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 201000010930 hyperostosis Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001258 synovial membrane Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to field of traditional Chinese, be specifically related to a kind of Chinese medicine preparation treating hyperosteogeny.This Chinese medicine preparation is made up of the raw material of Chinese medicine of following parts by weight: Radix Rehmanniae Preparata 60 90 parts, Fructus Corni 30 45 parts, Rhizoma Dioscoreae 30 45 parts, Radix Adenophorae (Radix Glehniae) 30 45 parts, Radix Morindae Officinalis 24 30 parts, Fructus Psoraleae 24 30 parts, Rhizoma Drynariae 24 30 parts, the Rhizoma Atractylodis Macrocephalae 30 45 parts, Cortex Cinnamomi 15 24 parts, Herba Lycopodii 24 30 parts, Herba pyrolae japonicae 30 45 parts, Radix Angelicae Sinensis 30 45 parts, Radix Salviae Miltiorrhizae 24 30 parts, 15 24 parts of Flos Carthami, Caulis Spatholobi 24 30 parts, the Radix Paeoniae Alba 24 30 parts, Fructus Chaenomelis 15 24 parts, the Radix Astragali 24 30 parts, Radix Glycyrrhizae Preparata 10 15 parts.The all medicines of the present invention are harmonious and have nourishing the kidney and liver, Psoralen raw marrow, blood circulation promoting and blood stasis dispelling, the effect of old tissue regeneration promoting of dispelling, and treatment hyperosteogeny has determined curative effect, instant effect, cure rate is high, have no side effect, the feature such as safe and reliable.
Description
Technical field
The invention belongs to field of traditional Chinese, be specifically related to a kind of Chinese medicine preparation treating hyperosteogeny.
Background technology
Hyperosteogeny is also called hyperplastic osteoarthritis, osteoarthritis, degenerative joint disease, senile arthritis, hypertrophy
Property arthritis, be owing to constituting soft tissue degeneration, the degeneration such as the cartilage in joint, intervertebral disc, ligament, joint margins forms bony spur,
The changes such as synovial membrane is plump, and osteoclasia occurs, cause insecondary hyperosteogeny, cause joint deformity, when by abnormal load
Time, cause arthralgia, a kind of disease of the symptoms such as limitation of activity.Hyperostosis constitutional estranged and Secondary cases two kinds.
Hyperosteogeny have impact on the life of patient, reduces quality of life, brings many painful to patient.Existing control
Treat in the method for hyperosteogeny, still there is the length course for the treatment of, easily recurrence and the refractory problem such as more.
Summary of the invention
The technical problem to be solved is to provide a kind of nourishing the kidney and liver, Psoralen raw marrow, blood circulation promoting and blood stasis dispelling, old tissue regeneration promoting effect of dispelling
The Chinese medicine preparation for the treatment of hyperosteogeny, there is determined curative effect, instant effect, cure rate is high, have no side effect and safe and reliable
Feature.
The Chinese medicine preparation for the treatment of hyperosteogeny of the present invention, is made up of the raw material of Chinese medicine of following parts by weight: Radix Rehmanniae Preparata 60-90
Part, Fructus Corni 30-45 part, Rhizoma Dioscoreae 30-45 part, Radix Adenophorae (Radix Glehniae) 30-45 part, Radix Morindae Officinalis 24-30 part, Fructus Psoraleae 24-30 part, bone
Broken benefit 24-30 part, Rhizoma Atractylodis Macrocephalae 30-45 part, Cortex Cinnamomi 15-24 part, Herba Lycopodii 24-30 part, Herba pyrolae japonicae 30-45 part, Radix Angelicae Sinensis 30-45
Part, Radix Salviae Miltiorrhizae 24-30 part, Flos Carthami 15-24 part, Caulis Spatholobi 24-30 part, Radix Paeoniae Alba 24-30 part, Fructus Chaenomelis 15-24 part, Radix Astragali 24-30
Part and Radix Glycyrrhizae Preparata 10-15 part.
The Chinese medicine preparation optimization formula of described treatment hyperosteogeny is as follows: Radix Rehmanniae Preparata 60 parts, Fructus Corni 30 parts, Rhizoma Dioscoreae 45 parts,
Radix Adenophorae (Radix Glehniae) 30 parts, Radix Morindae Officinalis 24 parts, Fructus Psoraleae 24 parts, Rhizoma Drynariae 30 parts, the Rhizoma Atractylodis Macrocephalae 45 parts, Cortex Cinnamomi 15 parts, Herba Lycopodii 30
Part, Herba pyrolae japonicae 30 parts, Radix Angelicae Sinensis 30 parts, Radix Salviae Miltiorrhizae 24 parts, 15 parts of Flos Carthami, Caulis Spatholobi 30 parts, the Radix Paeoniae Alba 30 parts, Fructus Chaenomelis 24
Part, the Radix Astragali 30 parts and Radix Glycyrrhizae Preparata 15 parts.
The present invention is also known as " Ren Shi bone rather dissipates ", and preparation method is conventional Chinese powder medicine preparation method:
Raw material of Chinese medicine is got all the ready, strict remove impurity, concoct by processing of medical material specification, be then crushed to 150 ~ 200 mesh, be dried
Rear protection against the tide is sealed up for safekeeping.
Function: nourishing the kidney and liver, Psoralen raw marrow, blood circulation promoting and blood stasis dispelling, the effect of old tissue regeneration promoting of dispelling.
Instructions of taking: 30g every time, takes 2 times, within one month, is a course for the treatment of day.
Cure mainly and indication: be used for treating hyperosteogeny.
Drug action mechanism:
(1) Radix Rehmanniae Preparata: sweet in the mouth, warm in nature；Return liver, kidney channel；Essence moist, beneficial of enriching blood fills out marrow.
(2) Fructus Corni: sour in the mouth, puckery, slightly warm in nature；Return liver, kidney channel；Liver and kidney tonifying, restrain astringent or styptic treatment for spontaneous sweating, controlling nocturnal emission with astringent drugs reducing urination, leukorrhagia stopping
Only collapse.
(3) Rhizoma Dioscoreae: sweet in the mouth, property is put down；Return spleen, lung, kidney channel, spleen reinforcing nourishing the stomach, the lung benefiting that promotes the production of body fluid, the kidney invigorating arresting seminal emission.
(4) Radix Adenophorae (Radix Glehniae): sour in the mouth, sweet, slightly warm in nature；Return spleen, stomach, Liver Channel；Nourishing YIN and clearing away lung-heat, reinforcing stomach reg fluid, QI invigorating, reduce phlegm.
(5) Radix Morindae Officinalis: acrid in the mouth, sweet；Warm in nature；Return liver, kidney channel；Reinforcing the kidney and supporting YANG, bone and muscle strengthening, expelling wind and removing dampness.
(6) Fructus Psoraleae: acrid in the mouth, hardship, warm in nature；Return kidney, pericardium, spleen, stomach, lung meridian；Reinforcing the kidney and supporting YANG, helping inspiration to relieve asthma, temperature
Spleen antidiarrheal.
(7) Rhizoma Drynariae: bitter in the mouth, warm in nature；Return kidney, Liver Channel；The kidney invigorating bone strengthening, continuous hinder pain relieving, for lumbago due to renal deficiency, tinnitus ear
Deaf, odontoseisis.
(8) Rhizoma Atractylodis Macrocephalae: bitter in the mouth, sweet, warm in nature, return spleen, stomach warp；Invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive.
(9) Cortex Cinnamomi: acrid in the mouth, sweet, extremely hot in nature；Return kidney, spleen, the heart, Liver Channel；Mend fire supporing yang, let the fire back to its origin, dispersing cold for relieving pain,
Promoting blood circulation to restore menstrual flow.
(10) Herba Lycopodii: acrid in the mouth, hardship, warm in nature；Return Liver Channel；Expelling wind and cold, dehumidifying detumescence, relaxing muscles and tendons and activating QI and blood in the collateral.
(11) Herba pyrolae japonicae: qi-restoratives, kidney tonifying, expelling wind and removing dampness, promoting blood flow to regulate menstruation, control weak cough, over-strained hemoptysis, Fengshi Guanjie
Bitterly.
(12) Radix Angelicae Sinensis: warm in nature, sweet in the mouth, pungent；Return liver, the heart, spleen channel；Replenishing and activating blood, menstruction regulating and pain relieving, loosening bowel to relieve constipation；With
In blood deficiency and yellow complexion, dizziness cardiopalmus, menoxenia, amenorrhea dysmenorrhea, asthenia cold abdominalgia, dryness of the intestine constipation, rheumatic arthralgia, injury from falling down,
Ulcer sores.
(13) Radix Salviae Miltiorrhizae: bitter in the mouth, is slightly cold；GUIXIN, Liver Channel；Promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, the relieving restlessness that clears away heart-fire,
Nourishing blood to tranquillize the mind.
(14) Flos Carthami: acrid in the mouth, warm in nature, GUIXIN, Liver Channel.Promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing.
(15) Caulis Spatholobi: bitter in the mouth, sweet, warm in nature；Return liver, kidney channel；Enrich blood, invigorate blood circulation, dredging collateral, for menoxenia, blood
Empty sallow, paralysis and numbness, rheumatic arthralgia.
(16) Radix Paeoniae Alba: bitter in the mouth, acid, cool in nature；Return liver, spleen channel；Nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing receive antiperspirant.
(17) Fructus Chaenomelis: sweet in the mouth, property is put down, is slightly cold；Return liver, spleen channel.Cure mainly numbness of the skin, arthralgia.
(18) Radix Astragali: sweet in the mouth, slightly warm in nature；Return lung, spleen, liver, kidney channel；Benefiting QI for strengthening the superficies, arresting sweating are admittedly de-, torr skin ulcer granulation promoting,
Effect of inducing diuresis to remove edema.
(19) Radix Glycyrrhizae Preparata: sweet in the mouth, property is put down；GUIXIN, lung, spleen, stomach warp；Spleen reinforcing stomach function regulating, Yiqi and vein recovery.
In the present invention:
Radix Rehmanniae Preparata, Fructus Corni, Rhizoma Dioscoreae, Radix Adenophorae (Radix Glehniae), Radix Morindae Officinalis, Fructus Psoraleae, Rhizoma Drynariae, the Rhizoma Atractylodis Macrocephalae, Cortex Cinnamomi nourishing the kidney and liver, Psoralen
Raw marrow；Herba Lycopodii, Herba pyrolae japonicae, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Flos Carthami, Caulis Spatholobi, the Radix Paeoniae Alba, Fructus Chaenomelis, the Radix Astragali, Radix Glycyrrhizae Preparata blood circulation promoting and blood stasis dispelling,
Dispel old tissue regeneration promoting.
Outcome measure:
Recovery from illness: bone joint pain disappears, and CR shows osteoarthrosis no abnormality seen, do not recurs in 1 year.
Taking a turn for the better: bone joint pain disappears, CR shows osteoarthrosis no abnormality seen, but time interval length, bone joint pain recurs again,
But pain degree alleviates.
Invalid: bone joint pain does not disappears, CR display osteoarthrosis is shown in exception.
Therapeutic outcome:
By clinical observation 80 cases, patient takes " Ren Shi bone rather dissipates ", each 30g, takes day 2 times, takes 2 continuously
The individual course for the treatment of, effective 75%, effective 20%, invalid 5%, total effective rate 90%.
Model case is enumerated:
Case 1:
Patient king so-and-so, Zhang Jiapo people from village, Zhang Jiapo town, man, 56 years old, in June, 2011, medical to here, double knee joint ached
Bitterly, dysstasia of squatting down, night, double knee joint was sent out cool, is CR to county people's hospital and shows: double knee joint degeneration.Take this
Medicine recovery from illness in 2 months, follows up a case by regular visits to recur the most again.
Case 2:
Patient Zhang, Bao Quan people from village, Zhang Jiapo town, female, 47 years old, in April, 2011, medical to here, patient's readme lower limb was anxious
Bitterly, can not fall asleep in the evening, and before 3 years, the most often sensation one leg is numb, sometimes seems not sensation, does not makes power, waist have
Time also pain.After being CT to county people's hospital, it is diagnosed as waist hyperosteogeny, takes the recovery from illness in 3 months of this medicine.In October, 2012
Telephone contact on the 3rd I, hyperosteogeny recurs the most again, represent thank very much.
Case 3:
Patient appoints so-and-so, Zhang Jiapo people from village, Zhang Jiapo town, man, 67 years old, in February, 2011, and medical to here, February 4 existed
Town commune hospital checks treatment, has opened 4 secondary Chinese medicines, DeGrain；February 10 checked treatment in county people's hospital, was CT
After, it is diagnosed as waist hyperosteogeny, doctor prescribed point medicine, then do physical therapy, doctor says and first does physical therapy in 10 days, then see effect.
Having done now physical therapy in 7 days, sensation lower limb the most a little aches and numb.Take the recovery from illness in 3 months of this medicine, follow up a case by regular visits to the most multiple
Send out.
Beneficial effects of the present invention is as follows:
The all medicines of the present invention are harmonious and have nourishing the kidney and liver, Psoralen raw marrow, blood circulation promoting and blood stasis dispelling, the effect of old tissue regeneration promoting of dispelling, and treat hyperosteogeny
Disease has determined curative effect, instant effect, cure rate is high, have no side effect, the feature such as safe and reliable.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
The Chinese medicine preparation for the treatment of hyperosteogeny of the present invention, is made up of the raw material of Chinese medicine of following parts by weight: Radix Rehmanniae Preparata 60 parts,
Fructus Corni 30 parts, Rhizoma Dioscoreae 45 parts, Radix Adenophorae (Radix Glehniae) 30 parts, Radix Morindae Officinalis 24 parts, Fructus Psoraleae 24 parts, Rhizoma Drynariae 30 parts, the Rhizoma Atractylodis Macrocephalae 45
Part, Cortex Cinnamomi 15 parts, Herba Lycopodii 30 parts, Herba pyrolae japonicae 30 parts, Radix Angelicae Sinensis 30 parts, Radix Salviae Miltiorrhizae 24 parts, 15 parts of Flos Carthami, Caulis Spatholobi
30 parts, the Radix Paeoniae Alba 30 parts, Fructus Chaenomelis 24 parts, the Radix Astragali 30 parts and Radix Glycyrrhizae Preparata 15 parts.
Preparation method:
Raw material of Chinese medicine is got all the ready, strict remove impurity, concoct by processing of medical material specification, be then crushed to 200 mesh, be dried rear defence
Tide is sealed up for safekeeping.
Embodiment 2
The Chinese medicine preparation for the treatment of hyperosteogeny of the present invention, is made up of the raw material of Chinese medicine of following parts by weight: Radix Rehmanniae Preparata 70 parts,
Fructus Corni 35 parts, Rhizoma Dioscoreae 30 parts, Radix Adenophorae (Radix Glehniae) 45 parts, Radix Morindae Officinalis 30 parts, Fructus Psoraleae 30 parts, Rhizoma Drynariae 24 parts, the Rhizoma Atractylodis Macrocephalae 30
Part, Cortex Cinnamomi 18 parts, Herba Lycopodii 27 parts, Herba pyrolae japonicae 45 parts, Radix Angelicae Sinensis 35 parts, Radix Salviae Miltiorrhizae 27 parts, 21 parts of Flos Carthami, Caulis Spatholobi
24 parts, the Radix Paeoniae Alba 24 parts, Fructus Chaenomelis 15 parts, the Radix Astragali 27 parts and Radix Glycyrrhizae Preparata 12 parts.
Preparation method is with embodiment 1.
Embodiment 3
The Chinese medicine preparation for the treatment of hyperosteogeny of the present invention, is made up of the raw material of Chinese medicine of following parts by weight: Radix Rehmanniae Preparata 80 parts,
Fructus Corni 45 parts, Rhizoma Dioscoreae 35 parts, Radix Adenophorae (Radix Glehniae) 40 parts, Radix Morindae Officinalis 27 parts, Fructus Psoraleae 27 parts, Rhizoma Drynariae 24 parts, the Rhizoma Atractylodis Macrocephalae 35
Part, Cortex Cinnamomi 24 parts, Herba Lycopodii 30 parts, Herba pyrolae japonicae 40 parts, Radix Angelicae Sinensis 40 parts, Radix Salviae Miltiorrhizae 30 parts, 24 parts of Flos Carthami, Caulis Spatholobi
30 parts, the Radix Paeoniae Alba 30 parts, Fructus Chaenomelis 18 parts, the Radix Astragali 24 parts and Radix Glycyrrhizae Preparata 10 parts.
Preparation method is with embodiment 1.
Embodiment 4
The Chinese medicine preparation for the treatment of hyperosteogeny of the present invention, is made up of the raw material of Chinese medicine of following parts by weight: Radix Rehmanniae Preparata 90 parts,
Fructus Corni 40 parts, Rhizoma Dioscoreae 40 parts, Radix Adenophorae (Radix Glehniae) 35 parts, Radix Morindae Officinalis 24 parts, Fructus Psoraleae 24 parts, Rhizoma Drynariae 27 parts, the Rhizoma Atractylodis Macrocephalae 40
Part, Cortex Cinnamomi 21 parts, Herba Lycopodii 24 parts, Herba pyrolae japonicae 35 parts, Radix Angelicae Sinensis 45 parts, Radix Salviae Miltiorrhizae 24 parts, 18 parts of Flos Carthami, Caulis Spatholobi
27 parts, the Radix Paeoniae Alba 27 parts, Fructus Chaenomelis 21 parts, the Radix Astragali 30 parts and Radix Glycyrrhizae Preparata 15 parts.
Preparation method is with embodiment 1.
Claims (2)
1. the Chinese medicine preparation treating hyperosteogeny, it is characterised in that be made up of the raw material of Chinese medicine of following parts by weight: Radix Rehmanniae Preparata
60-90 part, Fructus Corni 30-45 part, Rhizoma Dioscoreae 30-45 part, Radix Adenophorae (Radix Glehniae) 30-45 part, Radix Morindae Officinalis 24-30 part, Fructus Psoraleae 24-30
Part, Rhizoma Drynariae 24-30 part, Rhizoma Atractylodis Macrocephalae 30-45 part, Cortex Cinnamomi 15-24 part, Herba Lycopodii 24-30 part, Herba pyrolae japonicae 30-45 part, when
Return 30-45 part, Radix Salviae Miltiorrhizae 24-30 part, Flos Carthami 15-24 part, Caulis Spatholobi 24-30 part, Radix Paeoniae Alba 24-30 part, Fructus Chaenomelis 15-24 part,
Radix Astragali 24-30 part and Radix Glycyrrhizae Preparata 10-15 part.
The Chinese medicine preparation for the treatment of hyperosteogeny the most according to claim 1, it is characterised in that by the Chinese medicine of following parts by weight
Raw material is made: Radix Rehmanniae Preparata 60 parts, Fructus Corni 30 parts, Rhizoma Dioscoreae 45 parts, Radix Adenophorae (Radix Glehniae) 30 parts, Radix Morindae Officinalis 24 parts, Fructus Psoraleae 24
Part, Rhizoma Drynariae 30 parts, the Rhizoma Atractylodis Macrocephalae 45 parts, Cortex Cinnamomi 15 parts, Herba Lycopodii 30 parts, Herba pyrolae japonicae 30 parts, Radix Angelicae Sinensis 30 parts, Radix Salviae Miltiorrhizae
24 parts, 15 parts of Flos Carthami, Caulis Spatholobi 30 parts, the Radix Paeoniae Alba 30 parts, Fructus Chaenomelis 24 parts, the Radix Astragali 30 parts and Radix Glycyrrhizae Preparata 15 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210488206.4A CN102935163B (en) | 2012-11-26 | 2012-11-26 | The Chinese medicine preparation for the treatment of hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210488206.4A CN102935163B (en) | 2012-11-26 | 2012-11-26 | The Chinese medicine preparation for the treatment of hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102935163A CN102935163A (en) | 2013-02-20 |
| CN102935163B true CN102935163B (en) | 2016-07-13 |
Family
ID=47694110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210488206.4A Expired - Fee Related CN102935163B (en) | 2012-11-26 | 2012-11-26 | The Chinese medicine preparation for the treatment of hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102935163B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393879B (en) * | 2013-07-24 | 2015-05-20 | 于宁 | Traditional Chinese medicine composition for treating liver and kidney deficiency |
| CN105106456A (en) * | 2015-09-02 | 2015-12-02 | 张家道 | Traditional Chinese medicine composition for treating bone fracture |
| CN111419893B (en) * | 2020-04-22 | 2021-08-03 | 淄博维希尔生物技术有限公司 | Pharmaceutical composition for treating duck leg tenderness |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1150910A (en) * | 1996-04-18 | 1997-06-04 | 花茂时 | Osteophytosis pill and its compounding method |
-
2012
- 2012-11-26 CN CN201210488206.4A patent/CN102935163B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1150910A (en) * | 1996-04-18 | 1997-06-04 | 花茂时 | Osteophytosis pill and its compounding method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102935163A (en) | 2013-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104547790A (en) | Traditional Chinese medicine composition for treating rheumatic arthritis and preparation method thereof | |
| CN103349753B (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN100512847C (en) | Chinese traditional medicine compound took orally for treating cervical spondylosis | |
| CN103463586B (en) | A kind of Chinese medicine composition for the treatment of restless legs syndrome | |
| CN103110762A (en) | Traditional Chinese medicine composition for treating old fracture | |
| CN103316145B (en) | A kind of Traditional Chinese medicine foot soaping liquid and preparation method for the treatment of lower limb distending pain | |
| CN102247458B (en) | Capsule for warming collaterals and relaxing tendons | |
| CN102085346B (en) | Traditional Chinese medicine composition for treating chronic obstructive pulmonary disease | |
| CN102935163B (en) | The Chinese medicine preparation for the treatment of hyperosteogeny | |
| CN104623232A (en) | Traditional Chinese medicine composition for treating tinnitus | |
| CN103990085A (en) | Traditional Chinese medicine for treating rheumatoid arthritis | |
| CN104623148A (en) | Medicament for treating cough and asthma and preparation method of oral liquid thereof | |
| CN103330814B (en) | A kind of Chinese medicine composition for the treatment of insufficiency of kidney-YANG | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN104606399A (en) | Traditional Chinese medicine ointment for treating scleroderma and preparation method of Traditional Chinese medicine ointment | |
| CN104435549A (en) | Traditional Chinese medicine for treating wind-cold-dampness arthralgia type femoral head necrosis | |
| CN104257851B (en) | A kind of Chinese medicine composition for the treatment of kidney deficiency blood stasis type femur head necrosis | |
| CN103520569B (en) | Traditional Chinese medicine for treatment of lumbago of syndrome of yin deficiency of liver and kidney | |
| CN102988630A (en) | Pharmaceutical composition for treating gout disease, and preparation method thereof | |
| CN101703626B (en) | Medicament for treating rheumatoid arthritis | |
| CN105288158A (en) | Traditional Chinese medicine for treatment of cold-dampness type chronic rhinitis | |
| CN105833152A (en) | Traditional Chinese medicine composition for treating endocrine dyscrasia | |
| CN105770834B (en) | A kind of Chinese medicinal pill for treating polymyalgia rheumatica | |
| CN104173931A (en) | Traditional Chinese medicine composition for treating trauma | |
| CN104173767A (en) | Traditional Chinese medicine capsule for treating neurasthenia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhao Nana Inventor after: Yu Feixiang Inventor after: Zhang Zhongshou Inventor after: Li Zhongcheng Inventor before: Ren Yujin Inventor before: Liu Jizhen |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160603 Address after: 266109, 101, building 4, building 480, 10 Hua Cheng Road, Chengyang District, Shandong, Qingdao Applicant after: Li Zhongcheng Address before: 256100 Shandong city of Zibo province Yiyuan County Zhangjiapo town government Applicant before: Ren Yujin |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210122 Address after: 274600 north section of juanwu Road, juancheng County, Heze City, Shandong Province Patentee after: Juancheng ma'aiyun women's and children's Hospital Address before: 266109 101 unit 4, 10 building, 480 Huacheng Road, Chengyang District, Qingdao, Shandong. Patentee before: Li Zhongcheng |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160713 |